Point72 Middle East FZE’s Edwards Lifesciences EW Stock Holding History

Point72 Middle East FZE’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,693	Closed	-$1.51M	–	1606
2023 Q3	$1.5M	Buy	+21,693	New	+$1.74M	0.05%	435
2023 Q1	–	Sell	-499	Closed	-$39.2K	–	1795
2022 Q4	$37.2K	Buy	+499	New	+$38.5K	﹤0.01%	1520

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Point72 Middle East FZE's EW Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 21,693 shares — an estimated $1.51M sold.

Point72 Middle East FZE first reported a position in EW in Q4 2022 and held it in 2 quarters. The position peaked at $1.5M in Q3 2023. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

Point72 Middle East FZE reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
Point72 Middle East FZE sold 21,693 Edwards Lifesciences shares in Q4 2023, an estimated $1.51M.
Point72 Middle East FZE first reported a position in Edwards Lifesciences in Q4 2022 and held it in 2 quarters.
Point72 Middle East FZE's Edwards Lifesciences position peaked at $1.5M in Q3 2023.
1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.